ArrowMark Partners

ArrowMark Partners

ArrowMark Partners

MedCity News

Centrexion Therapeutics changes its mind on initial public offering

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$200,000,000 IPO
PE Hub , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
Xconomy

Centrexion Plans IPO to Bankroll Non-Opioid Pain Drugs

TechCrunch

Convene uses landlord partnership model to outclass WeWork

Apps & Services
PE Hub

Kodiak debuts IPO

PE Hub

Kodiak Sciences sets IPO pricing terms

Xconomy

Kodiak Sciences Files for IPO to Fund Global AMD Eye-Drug Studies

GeekWire

Why Seattle’s plan to bring Intersection WiFi kiosks and bus stop makeovers stalled

$80,000,000 Venture capital (Series D)
FinSMEs

Evolve Vacation Rental Network Raises $80M

Funding Travel
ChinaMoneyNetwork

Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

$150,000,000 Venture capital (Series C)
FinSMEs

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
$150,000,000 Venture capital (Series C)
PE Hub , AVCJ , FinSMEs

Ascentage Pharma takes in about $150 mln

Data leaks Messaging
$152,000,000 Venture capital (Series D)
PE Hub

Convene takes in $152 mln Series D

Messaging
FinSMEs

Convene Secures $152M in Series D Funding

Funding
TechCrunch , CrunchBase

WeWork competitor Convene raises a $152 million Series D

City life Funding
PE Hub

VC-backed Neon Therapeutics goes public

Stock markets Costs Health
$110,000,000 Venture capital (Series B)
FinSMEs

Precision BioSciences Raises $110M in Series B Funding

Funding
$65,000,000 Venture capital (Series C)
PE Hub , FinSMEs

Metacrine nabs $65 mln Series C

Messaging
$33,000,000 Venture capital
FinSMEs

Kodiak Sciences Closes $33M Mezzanine Private Financing

Funding